News
ABIO
3.210
-1.83%
-0.060
Weekly Report: what happened at ABIO last week (0408-0412)?
Weekly Report · 2d ago
Weekly Report: what happened at ABIO last week (0401-0405)?
Weekly Report · 04/08 12:18
ARCA biopharma 13D Filing Shows Adage Capital Management, L.P. Reported A 8.28% Stake In The Co As Of April 3, 2024
Benzinga · 04/05 20:17
ADAGE CAPITAL MANAGEMENT, L.P. REPORTS 8.28% STAKE IN ARCA BIOPHARMA AS OF APRIL 3- SEC FILING
Reuters · 04/05 20:16
ARCA Biopharma stock drops on CEO departure
ARCA Biopharma shares down about 7% premarket after company and CEO Michael Bristow mutually agreed to conclude Bristow’s employment and service as a director. The Board appointed Thomas Keuer to serve as ARCA's President and principal executive officer. ARCA biopharma stock drops on CEO departure.
Seeking Alpha · 04/05 13:06
Altice USA, Genfit, Brooge Energy among premarket losers' pack
On the Move: Altice USA, Genfit, Brooge Energy among premarket losers' pack. HWH International, ARCA biopharma, ZCMD, HWH among the biggest morning stock movers. ATUS, GNFT, BROG and HWH are among the morning's biggest losers.
Seeking Alpha · 04/05 12:29
ARCA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIO
Former Attorney General of Louisiana Charles C. Foti, Jr. And the law firm of Kahn Swick & Foti are investigating the proposed merger of ARCA biopharma, Inc. And Oruka Therapeutics. KSF is seeking to determine whether the merger is fair to ARCA shareholders.
Barchart · 04/05 12:27
Arca Biopharma Announces Executive Leadership Transition
TipRanks · 04/04 20:43
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
STAAR Surgical shares jumped 13.3% to $44.30 on Thursday. The company issued strong preliminary first-quarter net sales guidance. TC Biopharm (Holdings) Plc shares climbed 130.1% in the mid-day session.
Benzinga · 04/04 17:21
ARCA biopharma, Achilles Therapeutics, MSP Recovery among healthcare movers
Healthcare On the Move ARCA biopharma, Achilles Therapeutics, MSP Recovery among healthcare movers. S&P 500 Health Care Sector +0.45% to 1687.02. Pharmaceuticals, Biotechnology & Life Science contributes 58% to index.
Seeking Alpha · 04/04 14:00
EC, ABAT and BORR among pre-market losers
On the Move EC, ABAT and BORR among pre-market losers. Keyarch Acquisition Corp (KYCH) reports fourth quarter and year-end 2023 financial results and recent business highlights. ABIO, XTIA, CGC, HSDT, ONMD, KYCH and ABAT also lose ground.
Seeking Alpha · 04/04 12:25
Why Flora Growth Shares Are Trading Lower By Around 20%; Here Are 20 Stocks Moving Premarket
Shares of Flora Growth Corp. Fell sharply in today's pre-market trading. The company reported the launch of a proposed public offering of common shares. Levi Strauss & Co. Shares rose 7.9% on Wednesday after the company reported upbeat earnings for its first quarter. HWH International Inc. And VivoPower surged 175% and 14.5% in pre- market trading.
Benzinga · 04/04 11:58
Nasdaq Gains 75 Points; Acuity Brands Posts Upbeat Earnings
The Dow traded up 0.08% to 39,200.08 while the NASDAQ rose 0.46% on Wednesday. U.S. Stocks traded higher toward the end of trading, with the S&P 500 gaining around 0.3%. Acuity Brands, Inc. Reported better-than-expected earnings for its second quarter. European shares closed higher today; Asian markets closed lower.
Benzinga · 04/03 18:30
Why Is ARCA Biopharma (ABIO) Stock Up 85% Today?
ABIO stock will be merged with Oruka in an all-stock merger. The company will focus on advancing its pipeline of potentially best-in-class biologics. The psoriasis treatment market size is a viable one for OruKA. ABIO shares have gained 90% since the beginning of the year.
Investorplace · 04/03 18:30
BUZZ-U.S. STOCKS ON THE MOVE-Identiv, Levi Strauss, cannabis firms
Wall Street's main indexes advanced on Wednesday. Softer-than-expected services sector data offered relief to investors. Dow Jones Industrial Average was up 0.14% at 39,226.61. Top three S&P 500 percentage gainers: GE Aerospace, Caesars Entertainment, Ulta Beauty.
Reuters · 04/03 18:01
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Ulta Beauty shares dipped 13.7% to $448.08 on Wednesday. The company reportedly issued a weak outlook at the J.P. Morgan Retail Roundup investor conference. ARCA biopharma, Inc. Shares climbed 108% in the mid-day session.
Benzinga · 04/03 17:56
12 Health Care Stocks Moving In Wednesday's Intraday Session
ARCA biopharma (NASDAQ:ABIO) shares moved upwards by 84.8% to $3.16 during Wednesday's regular session. Vanda Pharma shares rose by 39.38% and Kintara Therapeutics stock rose by 71.81% in the same session. The company's Q4 earnings report came out yesterday.
Benzinga · 04/03 16:31
Crude Oil Moves Higher; ISM Services PMI Falls In March
U.S. Stocks traded higher midway through trading on Wednesday. The Nasdaq Composite gained over 0.5% and the Dow traded up 0.18%. The ISM services PMI declined to 51.4 in March compared to market estimates of 52.7. Kintara Therapeutics, Inc. Shares jumped after the company announced a merger agreement. Asian markets closed lower on Wednesday; European shares mostly higher.
Benzinga · 04/03 16:01
BUZZ-U.S. STOCKS ON THE MOVE-Spotify, Ulta Beauty, SPAR Group
Spotify, Ulta Beauty, SPAR Group are among the day's top stocks. Wall Street's main indexes swung higher on Wednesday after softer-than-expected services sector data. The Dow Jones Industrial Average was up 0.21% at 39,252.29.
Reuters · 04/03 15:57
BUZZ-ARCA Biopharma surges on deal to merge with Oruka Therapeutics
Shares of ARCA Biopharma more than double to a three-year high of $3.82. Company to merge with private biotech Oruka Therapeutics in an all-stock deal. Stock set for its biggest one day gain in four years if gains hold.
Reuters · 04/03 14:53
More
Webull provides a variety of real-time ABIO stock news. You can receive the latest news about Arca Biopharma Inc through multiple platforms. This information may help you make smarter investment decisions.
About ABIO
ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company engaged in developing genetically and other targeted therapies for cardiovascular diseases through a precision medicine approach to drug development. The Company's lead product candidate is Gencaro (bucindolol hydrochloride) for the treatment of atrial fibrillation (AF) in patients with chronic heart failure (HF). Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy. Gencaro is a pharmacogenetically-targeted beta-adrenergic receptor antagonist with mild vasodilator properties that is developing for the treatment of atrial fibrillation in patients with heart failure. Its Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), is a protein therapeutic in clinical development as a potential treatment for patients with COVID-19. It is also evaluating options for development of its assets, including partnering and other strategic options.